Interactions of a Tetrazine Derivative with Biomembrane Constituents: A Langmuir Monolayer Study.
Tetrazine (Tz) is expected to be used for bioimaging and as an analytical reagent. It is known to react very fast with trans-cyclooctene under water in organic chemistry. Here, to understand the interaction between Tz and biomembrane constituents, we first investigated the interfacial behavior of a newly synthesized Tz derivative comprising a C18-saturated hydrocarbon chain (rTz-C18) using a Langmuir monolayer spread at the air-water interface. Surface pressure (π)-molecular area (A) and surface potential (ΔV)-A isotherms were measured for monolayers of rTz-C18 and biomembrane constituents such as dipalmitoylphosphatidylcholine (DPPC), dipalmitoylphosphatidylglycerol (DPPG), dipalmitoyl phosphatidylethanolamine (DPPE), palmitoyl sphingomyelin (PSM), and cholesterol (Ch). The lateral interaction between rTz-C18 and the lipids was thermodynamically elucidated from the excess Gibbs free energy of mixing and two-dimensional phase diagram. The binary monolayers except for the Ch system indicated high miscibility or affinity. In particular, rTz-C18 was found to interact more strongly with DPPE, which is a major constituent of the inner surface of cell membranes. The phase behavior and morphology upon monolayer compression were investigated by using Brewster angle microscopy (BAM), fluorescence microscopy (FM), and atomic force microscopy (AFM). The BAM and FM images of the DPPC/rTz-C18, DPPG/rTz-C18, and PSM/rTz-C18 systems exhibited a coexistence state of two different liquid-condensed domains derived mainly from monolayers of phospholipids and phospholipids-rTz-C18. From these morphological observations, it is worthy to note that rTz-C18 is possible to interact with a limited amount of the lipids except for DPPE.
Department of Biophysical Chemistry, Graduate School of Pharmaceutical Sciences, Nagasaki International University , 2825-7 Huis Ten Bosch, Sasebo, Nagasaki 859-3298, Japan.
Hiromichi
H
Nakahara
Department of Pharmaceutical Informatics, Graduate School of Biomedical Sciences, Nagasaki University , 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
Masayori
M
Hagimori
Department of Biophysical Chemistry, Kobe Pharmaceutical University , 4-19-1 Motoyama Kitamachi, Higashinada-ku, Kobe 658-8558, Japan.
Takahiro
T
Mukai
Department of Biophysical Chemistry, Graduate School of Pharmaceutical Sciences, Nagasaki International University , 2825-7 Huis Ten Bosch, Sasebo, Nagasaki 859-3298, Japan.
Osamu
O
Shibata